BIOMARIN PHARMACEUTICAL INC 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed Dec 8, 2014
Insider Transaction Report
Form 4
LEWIS ALAN
Director
Transactions
- Sale
Common Stock
2014-12-04$89.90/sh−7,500$674,225→ 21,400 total - Exercise/Conversion
Common Stock
2014-12-04$21.51/sh+7,500$161,325→ 28,900 total - Exercise/Conversion
Stock Option (right to buy)
2014-12-04−7,500→ 0 totalExercise: $21.51From: 2010-11-12Exp: 2020-11-11→ Common Stock (7,500 underlying)
Footnotes (3)
- [F1]The price in column 4 is a weighted average price. The price actually received ranged from $89.8940 to $89.94. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F2]Option grant vest 6/48th on November 12, 2010, and 1/48 on the 12th day of every month thereafter
- [F3]Reflects the number of stock options outstanding after the transaction from this specific stock option grant.